Although upregulation of Foxp3/Treg cells is predictive of poor outcome in all receptor types of breast cancer (Liu et al. 2014, Miyashita et al. 2014), CD8+ T cells are not linked to prognosis in ER+ disease (Dushyanthen et al. 2015). This evidence concerns the gene FOXP3 and breast cancer.